Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Adenocarcinoma

Conditions:   Adenocarcinoma Esophagus;   Locally Advanced Adenocarcinoma;   Siewert Type I Adenocarcinoma of Esophagogastric Junction;   Siewert Type II Adenocarcinoma of Esophagogastric Junction Interventions:   Drug: Vactosertib;   Drug: Standard of Care Chemotherapy;   Radiation: Concurrent Radiation Sponsor:   Jennifer Eva Selfridge Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials